Zomig
Product Images NDC 64896-084

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Zomig (NDC 64896-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zomig Nasal Spray Grunenthal 1)

Chemical structure diagram of the active ingredient in ZOMIG, showing molecular bonds and functional groups including an indole ring, a lactam, and a dimethylaminoethyl side chain.*

FDA Label Image

5 mg Carton (Zomig Nasal Spray Grunenthal 10)

Packaging label for Zomig Nasal Spray 5 mg (zolmitriptan) by Amneal Pharmaceuticals LLC. The label indicates it is for intranasal use only and includes 6 single-use nasal spray devices. The packaging also includes storage instructions and manufacturer information, with a blue gradient design and the Amneal logo.*

FDA Label Image

Figure 1 (Zomig Nasal Spray Grunenthal 2)

A line graph depicting the estimated probability of response (%) over 4 hours from initial dose for three treatment groups: 2.5 mg nasal spray, 5.0 mg nasal spray, and placebo. The graph shows that both nasal spray doses result in higher response probabilities compared to placebo, with 5.0 mg nasal spray having the highest response rate over time.*

FDA Label Image

Figure 2 (Zomig Nasal Spray Grunenthal 3)

A line graph depicting the estimated probability (%) of taking escape medication over 24 hours from the initial dose. It compares three groups: 2.5 mg nasal spray, 5.0 mg nasal spray, and placebo, showing the time course of escape medication use for ZOMIG nasal spray doses and placebo.*

FDA Label Image

Figure 3 (Zomig Nasal Spray Grunenthal 4)

A line chart showing the estimated probability (%) of rescue medication use over time (hours) post dose for ZOMIG 5 mg versus placebo. Two lines represent groups: ZOMIG 5 mg (231 participants) with higher probability values and placebo (253 participants) with lower values over 24 hours.*

FDA Label Image

Figure A (Zomig Nasal Spray Grunenthal 5)

An instructional diagram labeled 'Figure A' showing hands manipulating two components of a device, one black and one white, with a curved arrow indicating how to connect or insert the black component into the white component. The image appears to demonstrate assembly or use steps for the product ZOMIG by Amneal Pharmaceuticals LLC.*

FDA Label Image

Figure B (Zomig Nasal Spray Grunenthal 6)

An illustration labeled 'Figure B' showing a woman touching or pointing to one side of her nose with her finger. The image appears instructional, possibly demonstrating a facial or nasal action.*

FDA Label Image

Figure C (Zomig Nasal Spray Grunenthal 7)

Illustration labeled Figure C showing a hand holding a small nasal spray device, likely related to the administration of ZOMIG nasal spray.*

FDA Label Image

Figure D (Zomig Nasal Spray Grunenthal 8)

An instructional illustration labeled 'Figure D' showing a person administering a nasal spray by placing the spray nozzle into one nostril and pressing it with a finger, demonstrating the correct technique for nasal spray use.*

FDA Label Image

2.5 mg Carton (Zomig Nasal Spray Grunenthal 9)

The packaging label for Zomig Nasal Spray contains zolmitriptan 2.5 mg for intranasal use only. The label features the brand name Zomig Nasal Spray prominently with dosage strength and administration route. It includes manufacturer details for Amneal Pharmaceuticals LLC and notes that each pack contains six single-use nasal spray devices. Storage instructions and usage warnings are visible, along with a barcode and space for lot and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.